InsiderTrades

Form 4 for IRMD IRADIMED CORP

Accepted 2023-12-11 00:00:00 ET · period of report 2023-12-07 · accession 0001415889-23-016251 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-12-11 2023-12-07 IRMD VUOTO ANTHONY Dir M - OptEx — +2,786 16.9K +20% —
DM 2023-12-11 2023-12-07 IRMD VUOTO ANTHONY Dir M - OptEx $0.00 -2,786 0 -100% $0
D 2023-12-11 2023-12-07 IRMD VUOTO ANTHONY Dir A - Grant $0.00 +2,393 4,144 +137% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-07 M A 1,036 — 15,174 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Common Common Stock 2023-12-07 M A 1,750 — 16,924 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2023-12-07 M D 1,750 $0.00 1,751 D — · — to — 1,750 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) On December 7, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
4 Derivative Restricted Stock Units 2023-12-07 A A 2,393 $0.00 4,144 D — · — to — 2,393 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
5 Derivative Restricted Stock Units 2023-12-07 M D 1,036 $0.00 0 D — · — to — 1,036 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On December 7, 2021, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.